Q32 Bio Inc.

NASDAQ: QTTB · Real-Time Price · USD
1.98
0.10 (5.32%)
At close: Aug 15, 2025, 3:59 PM
1.99
0.41%
After-hours: Aug 15, 2025, 07:01 PM EDT

Q32 Bio Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a 1.86M 354K 802K 802K 802K 802K 802K 802K 1.68M 2.19M 29.3M
Cost of Revenue
91K n/a n/a n/a 121K 123K n/a 136K 564K 587K 633K 635K 786K 545K 2.4M n/a n/a 29.3M
Gross Profit
-91K n/a n/a n/a -121K -123K n/a 1.72M -210K 215K 169K 167K 16K 257K -1.59M 1.68M 2.19M n/a
Operating Income
-9.17M -12.23M -14.53M -18.81M -17.92M -14.84M -9.41M -24.36M -30.82M -27.51M -34.49M -32.86M -28.31M -37.62M -33.63M -30.66M -30.55M -1.11M
Interest Income
n/a 700K 900K 1.2M 4.09M n/a 1.18M 1.42M 1.51M 1.47M 1.46M 1.27M 474K 32K 42K 53K 52K 38K
Pretax Income
-9.49M -11.03M -14.17M -17.59M -15.53M 1.21M -2.15M -29.58M -29.3M -26.04M -33.04M -31.59M -27.83M 93.66M -33.58M -30.61M -30.5M -1.07M
Net Income
-9.49M -11.03M -14.19M -17.59M -16.98M 1.03M -16.12M -32.95M -35.04M -28.84M -34.3M -33.73M -29.09M 92.11M -33.58M -30.61M -30.5M -1.07M
Selling & General & Admin
3.92M 5.1M 3.98M 4.47M 4.39M 5M 7.9M 6.71M 7.62M 7.74M 7.51M 7.17M 7.25M 13.6M 8.39M 5.95M 6.65M 6.3M
Research & Development
5.16M 7.12M 10.54M 14.35M 13.41M 9.84M 1.51M 17.52M 22.98M 19.99M 27.15M 25.85M 21.07M 24.27M 23.65M 23.99M 23.7M 21.75M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a 84K 165K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
9.08M 12.23M 14.53M 18.81M 17.8M 14.84M 9.41M 24.23M 30.61M 27.73M 34.66M 33.03M 28.32M 37.88M 32.03M 29.94M 30.35M 28.06M
Interest Expense
300K 300K n/a 300K 1.7M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -121K n/a n/a 4.51M 5.16M 5.33M 5.01M n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
9.17M 12.23M 14.53M 18.81M 17.92M 14.84M 9.41M 24.36M 31.17M 28.31M 35.3M 33.66M 29.11M 38.42M 34.43M 32.34M 32.74M 30.42M
Income Tax Expense
n/a n/a 21K n/a 1.45M -15.71M n/a n/a n/a n/a -101K -46K -105K 967K n/a n/a n/a n/a
Shares Outstanding (Basic)
12.2M 12.2M 12.18M 12.08M 11.96M 3.21M 3.22M 3.21M 3.21M 3.21M 3.19M 3.19M 3.19M 3.18M 3.18M 3.17M 3.14M 2.8M
Shares Outstanding (Diluted)
12.2M 12.2M 12.18M 12.08M 11.96M 3.21M 3.22M 3.21M 3.21M 3.21M 3.19M 3.19M 3.19M 3.22M 3.18M 3.17M 3.14M 2.8M
EPS (Basic)
-0.78 -0.9 -2.33 -1.46 -1.42 0.09 -5 -10.25 -10.91 -9 -10.74 -10.57 -9.12 28.94 -10.58 -9.65 -9.72 -0.38
EPS (Diluted)
-0.78 -0.9 -1.16 -1.46 -1.42 0.09 -5 -10.25 -10.91 -9 -10.74 -10.57 -9.12 28.65 -10.58 -9.65 -9.72 -0.38
EBITDA
-9.1M -10.61M 6.71M -18.69M -17.8M -14.72M -2.15M -24.23M -30.25M -26.92M -33.86M -32.23M -27.52M -37.07M -31.23M -28.26M -28.16M 1.29M
EBIT
-9.19M -10.73M 6.59M -18.81M -17.92M -14.84M -2.15M -7.8M -7.28M -7.37M -7.91M -31.59M -27.83M 93.66M -33.58M -30.61M -30.5M -1.07M
Depreciation & Amortization
91K 119K 120K 123K 121K 123K 43.81K 136K 564K 587K 633K 635K 786K 545K 2.4M 2.4M 2.39M 2.36M